| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $26.5M | -37.5% |
| SG&A Expense | $26.7M | +28.6% |
| Operating Income | -$53.1M | +15.8% |
| Pre-tax Income | -$59.0M | +10.7% |
| Income Tax | $3K | +0.0% |
| Net Income | -$59.0M | +10.7% |
| EPS (Basic) | -$0.24 | +22.6% |
| EPS (Diluted) | -$0.24 | +22.6% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.4M | +34.5% |
| Current Assets | $31.0M | +12.6% |
| Total Assets | $32.3M | +13.2% |
| Current Liabilities | $46.7M | +136.9% |
| Total Liabilities | $46.7M | +136.2% |
| Stockholders' Equity | -$14.4M | -265.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.0M | +24.2% |
| Financing Cash Flow | $49.0M | -17.8% |